Use of Medicines with Unknown Fetal Risk among Parturient Women from the 2004 Pelotas Birth Cohort (Brazil)

Background. To estimate the exposure to medicines with unknown fetal risk during pregnancy and to analyze the maternal characteristics associated with it. Methods. A questionnaire was administered to 4,189 mothers of children belonging to the 2004 Pelotas (Brazil) birth cohort study about use of any...

Full description

Saved in:
Bibliographic Details
Main Authors: Andréa Dâmaso Bertoldi, Tatiane da Silva Dal Pizzol, Aline Lins Camargo, Aluísio J. D. Barros, Alicia Matijasevich, Iná S. Santos
Format: Article
Language:English
Published: Wiley 2012-01-01
Series:Journal of Pregnancy
Online Access:http://dx.doi.org/10.1155/2012/257597
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849304335015477248
author Andréa Dâmaso Bertoldi
Tatiane da Silva Dal Pizzol
Aline Lins Camargo
Aluísio J. D. Barros
Alicia Matijasevich
Iná S. Santos
author_facet Andréa Dâmaso Bertoldi
Tatiane da Silva Dal Pizzol
Aline Lins Camargo
Aluísio J. D. Barros
Alicia Matijasevich
Iná S. Santos
author_sort Andréa Dâmaso Bertoldi
collection DOAJ
description Background. To estimate the exposure to medicines with unknown fetal risk during pregnancy and to analyze the maternal characteristics associated with it. Methods. A questionnaire was administered to 4,189 mothers of children belonging to the 2004 Pelotas (Brazil) birth cohort study about use of any medicine during gestation. We evaluated the associations between use of medicines with unknown fetal risk and the independent variables through logistic regression models. Unknown fetal risk was defined as medicines in which studies in animals have revealed adverse effects on the fetus, and no controlled studies in women, or studies in women and animals, are available. Results. Out of the 4,189 women, 52.5% used at least one medicine from unknown fetal risk. Use of these medicines was associated with white skin color, high schooling, high income, six or more antenatal care consultations, hospital admission during pregnancy, and morbidity during gestation. Conclusion. The use of unknown fetal risk medicines is high, suggesting that their use must be addressed with caution with the aim of restricting their use to cases in which the benefits are greater than the potential risks.
format Article
id doaj-art-10cd1db887ee4219b399a5cb310122fa
institution Kabale University
issn 2090-2727
2090-2735
language English
publishDate 2012-01-01
publisher Wiley
record_format Article
series Journal of Pregnancy
spelling doaj-art-10cd1db887ee4219b399a5cb310122fa2025-08-20T03:55:45ZengWileyJournal of Pregnancy2090-27272090-27352012-01-01201210.1155/2012/257597257597Use of Medicines with Unknown Fetal Risk among Parturient Women from the 2004 Pelotas Birth Cohort (Brazil)Andréa Dâmaso Bertoldi0Tatiane da Silva Dal Pizzol1Aline Lins Camargo2Aluísio J. D. Barros3Alicia Matijasevich4Iná S. Santos5Programa de Pós-Graduação em Epidemiologia, Universidade Federal de Pelotas, Rua Marechal Deodoro, 1160, 3 Piso, 96020-220 Pelotas, RS, BrazilPrograma de Pós-Graduação em Epidemiologia, Universidade Federal do Rio Grande do Sul, Rua Ramiro Barcelos, 2400, 2 Andar, 90035-003 Porto Alegre, RS, BrazilDepartamento de Ciências Básicas da Saúde, Universidade Federal de Ciências da Saúde de Porto Alegre, Rua Sarmento Leite, 245, 90050-170, Porto Alegre, RS, BrazilPrograma de Pós-Graduação em Epidemiologia, Universidade Federal de Pelotas, Rua Marechal Deodoro, 1160, 3 Piso, 96020-220 Pelotas, RS, BrazilPrograma de Pós-Graduação em Epidemiologia, Universidade Federal de Pelotas, Rua Marechal Deodoro, 1160, 3 Piso, 96020-220 Pelotas, RS, BrazilPrograma de Pós-Graduação em Epidemiologia, Universidade Federal de Pelotas, Rua Marechal Deodoro, 1160, 3 Piso, 96020-220 Pelotas, RS, BrazilBackground. To estimate the exposure to medicines with unknown fetal risk during pregnancy and to analyze the maternal characteristics associated with it. Methods. A questionnaire was administered to 4,189 mothers of children belonging to the 2004 Pelotas (Brazil) birth cohort study about use of any medicine during gestation. We evaluated the associations between use of medicines with unknown fetal risk and the independent variables through logistic regression models. Unknown fetal risk was defined as medicines in which studies in animals have revealed adverse effects on the fetus, and no controlled studies in women, or studies in women and animals, are available. Results. Out of the 4,189 women, 52.5% used at least one medicine from unknown fetal risk. Use of these medicines was associated with white skin color, high schooling, high income, six or more antenatal care consultations, hospital admission during pregnancy, and morbidity during gestation. Conclusion. The use of unknown fetal risk medicines is high, suggesting that their use must be addressed with caution with the aim of restricting their use to cases in which the benefits are greater than the potential risks.http://dx.doi.org/10.1155/2012/257597
spellingShingle Andréa Dâmaso Bertoldi
Tatiane da Silva Dal Pizzol
Aline Lins Camargo
Aluísio J. D. Barros
Alicia Matijasevich
Iná S. Santos
Use of Medicines with Unknown Fetal Risk among Parturient Women from the 2004 Pelotas Birth Cohort (Brazil)
Journal of Pregnancy
title Use of Medicines with Unknown Fetal Risk among Parturient Women from the 2004 Pelotas Birth Cohort (Brazil)
title_full Use of Medicines with Unknown Fetal Risk among Parturient Women from the 2004 Pelotas Birth Cohort (Brazil)
title_fullStr Use of Medicines with Unknown Fetal Risk among Parturient Women from the 2004 Pelotas Birth Cohort (Brazil)
title_full_unstemmed Use of Medicines with Unknown Fetal Risk among Parturient Women from the 2004 Pelotas Birth Cohort (Brazil)
title_short Use of Medicines with Unknown Fetal Risk among Parturient Women from the 2004 Pelotas Birth Cohort (Brazil)
title_sort use of medicines with unknown fetal risk among parturient women from the 2004 pelotas birth cohort brazil
url http://dx.doi.org/10.1155/2012/257597
work_keys_str_mv AT andreadamasobertoldi useofmedicineswithunknownfetalriskamongparturientwomenfromthe2004pelotasbirthcohortbrazil
AT tatianedasilvadalpizzol useofmedicineswithunknownfetalriskamongparturientwomenfromthe2004pelotasbirthcohortbrazil
AT alinelinscamargo useofmedicineswithunknownfetalriskamongparturientwomenfromthe2004pelotasbirthcohortbrazil
AT aluisiojdbarros useofmedicineswithunknownfetalriskamongparturientwomenfromthe2004pelotasbirthcohortbrazil
AT aliciamatijasevich useofmedicineswithunknownfetalriskamongparturientwomenfromthe2004pelotasbirthcohortbrazil
AT inassantos useofmedicineswithunknownfetalriskamongparturientwomenfromthe2004pelotasbirthcohortbrazil